TickerFactsScreenerDevelopers

TG THERAPEUTICS, INC. (TGTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$86.6K2017: -$93.76M2018: -$128.93M2019: -$132.81M2020: -$214.51M2021: -$295.63M2022: -$176.17M2023: -$31.41M2024: -$40.52M2025: -$24.77M-$24.77M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$24.77M+38.9%
2024-$40.52M-29.0%
2023-$31.41M+82.2%
2022-$176.17M+40.4%
2021-$295.63M-37.8%
2020-$214.51M-61.5%
2019-$132.81M-3.0%
2018-$128.93M-37.5%
2017-$93.76M—
2011-$86.6K—